Evidence map›Paper›PMID 32510873›Full record

ArticleMolecular genetics & genomic medicine2020

Clinical study and some molecular features of Mexican patients with syndromic craniosynostosis.

Aurora Ibarra-Arce, Manuel Almaraz-Salinas, Víctor Martínez-Rosas, Gabriela Ortiz de Zárate-Alarcón, Laura Flores-Peña, Mirza Romero-Valdovinos, Angélica Olivo-Díaz

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Aurora Ibarra-ArceDepartamento de Biología Molecular e Histocompatibilidad, Hospital General "Dr. Manuel Gea González", Ciudad de México, México.
Manuel Almaraz-SalinasDivisión de Genética, Hospital General "Dr. Manuel Gea González", Ciudad de México, México.
Víctor Martínez-RosasDivisión de Genética, Hospital General "Dr. Manuel Gea González", Ciudad de México, México.
Gabriela Ortiz de Zárate-AlarcónDivisión de Genética, Hospital General "Dr. Manuel Gea González", Ciudad de México, México.
Laura Flores-PeñaDivisión de Genética, Hospital General "Dr. Manuel Gea González", Ciudad de México, México.
Mirza Romero-ValdovinosDepartamento de Biología Molecular e Histocompatibilidad, Hospital General "Dr. Manuel Gea González", Ciudad de México, México.
Angélica Olivo-DíazDepartamento de Biología Molecular e Histocompatibilidad, Hospital General "Dr. Manuel Gea González", Ciudad de México, México.ORCID 0000-0003-0492-1504
Hospital General Dr. Manuel Gea Gonzalez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCraniosynostosis is one of the major genetic disorders affecting 1 in 2,100-2,500 live newborn children. Environmental and genetic factors are involved in the manifestation of this disease. The suggested genetic causes of craniosynostosis are pathogenic variants in FGFR1, FGFR2, FGFR3, and TWIST1 genes.

methodsIn order to describe their major clinical characteristics and the presence of pathogenic variants, a sample of 36 Mexican patients with craniosynostosis diagnosed as: Crouzon (OMIM 123,500), Pfeiffer (OMIM 101,600), Apert (OMIM 101,200), Saethre-Chotzen (OMIM 101,400), and Muenke (OMIM 602,849) was analyzed.

resultsIn addition to craniosynostosis, most of the patients presented hypertelorism, midface hypoplasia, and abnormalities in hands and feet. To detect the pathogenic variants p.Pro252Arg FGFR1 (OMIM 136,350), p.Ser252Trp, p.Pro253Arg FGFR2 (OMIM 176,943), p.Pro250Arg, FGFR3 (OMIM 134,934), and p.Gln119Pro TWIST1 (OMIM 601,622), PCR amplification and restriction enzyme digestion were performed. Four and two patients with Apert presented the pathogenic variants p.Ser252Trp and p.Pro253Arg in FGFR2, respectively (with a frequency of 11.1% and 5.5%). The p.Pro250Arg pathogenic variant of FGFR3 was found in a patient with Muenke (with a frequency of 2.8%). The above percentages were calculated with the total number of patients.

conclusionThe contribution of this work is discreet, since only 4 genes were analyzed and sample size is small. However, this strategy could be improved by sequencing the FGFR1, FGFR2, FGFR3, and TWIST1 genes, to determine different pathogenic variants. On the other hand, it would be important to include other genes, such as TCF12 (OMIM 600,480), MSX2 (OMIM 123,101), RAB23 (OMIM 606,144), and EFNB1 (OMIM 300,035), to determine their participation in craniosynostosis in the Mexican population.

Indexed as

PhenotypeAdultChildChild, PreschoolCraniosynostosesFemaleGene FrequencyHumansInfantMaleMexicoMutation, MissenseNuclear ProteinsReceptors, Fibroblast Growth FactorTwist-Related Protein 1Nuclear ProteinsReceptors, Fibroblast Growth FactorTWIST1 protein, humanTwist-Related Protein 1craniosynostosisFGFR genesgenetic variantsTWIST1

Identifiers

PMID32510873
PMCPMC7434736
OpenAlexW3033287445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.